Angela Coxon

8.1k total citations · 1 hit paper
92 papers, 4.3k citations indexed

About

Angela Coxon is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Angela Coxon has authored 92 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 29 papers in Oncology and 25 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Angela Coxon's work include Liver physiology and pathology (20 papers), Monoclonal and Polyclonal Antibodies Research (18 papers) and Cancer, Hypoxia, and Metabolism (14 papers). Angela Coxon is often cited by papers focused on Liver physiology and pathology (20 papers), Monoclonal and Polyclonal Antibodies Research (18 papers) and Cancer, Hypoxia, and Metabolism (14 papers). Angela Coxon collaborates with scholars based in United States, Germany and United Kingdom. Angela Coxon's co-authors include Tanya N. Mayadas, Teresa L. Burgess, M. Amin Arnaout, Ulrich H. von Andrian, Arlene H. Sharpe, Karen Rex, Jonathan D. Oliner, James Bready, Richard Kendall and Tanya N. Mayadas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

In The Last Decade

Angela Coxon

90 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Novel Role for the β2 Integrin CD11b/CD18 in Neutrophil Apoptosis: A Homeostatic Mechanism in Inflammation

1996 548 citations Angela Coxon et al. profile →

Peers

Countries citing papers authored by Angela Coxon

Since Specialization

Citations

This map shows the geographic impact of Angela Coxon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Coxon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Coxon more than expected).

Fields of papers citing papers by Angela Coxon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Coxon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Coxon. The network helps show where Angela Coxon may publish in the future.

Co-authorship network of co-authors of Angela Coxon

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Coxon. A scholar is included among the top collaborators of Angela Coxon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Coxon. Angela Coxon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The PSMA-targeting Half-life Extended BiTE Therapy AMG 160 has Potent Antitumor Activity in Preclinical Models of Metastatic Castration-resistant Prostate Cancer 2021 ·Clinical Cancer Research ·Petra Deegen, Oliver S. Thomas, Olivier Nolan-Stevaux, Shyun Li, Joachim Wahl, (unknown), Famke Aeffner, Matthias Friedrich, Michael Z. Liao, Katja Matthes, Doris Rau, Benno Rattel, Tobias Raum, Peter Kufer, Angela Coxon, Julie M. Bailis	58
2	Preclinical Assessment of a MUC12-Targeted BiTE (Bispecific T-cell Engager) Molecule 2021 ·Molecular Cancer Therapeutics ·Elizabeth Pham, Matthias G. Friedrich, Famke Aeffner, Michael Lutteropp, (unknown), Petra Deegen, (unknown), (unknown), (unknown), John M. Harrold, Christian Brandl, Natalia V. Grinberg, Benno Rattel, Angela Coxon, Julie M. Bailis	6
3	AMG 701 induces cytotoxicity of multiple myeloma cells and depletes plasma cells in cynomolgus monkeys 2020 ·Blood Advances ·Rebecca Goldstein, Ana Goyos, Chi-Ming Li, Petra Deegen, (unknown), Alexander Sternjak, Oliver S. Thomas, Matthias Klinger, Joachim Wahl, Matthias Friedrich, Benno Rattel, (unknown), Xiaoshan Min, Athena Sudom, (unknown), Angela Coxon, Mercedesz Balázs, Tara Arvedson	37
4	Targeting Multiple Myeloma with AMG 424, a Novel Anti-CD38/CD3 Bispecific T-cell–recruiting Antibody Optimized for Cytotoxicity and Cytokine Release 2019 ·Clinical Cancer Research ·Christina L. Zuch de Zafra, (unknown), Wendy Zhong, Matthew J. Bernett, Umesh S. Muchhal, Gregory L. Moore, Jennitte Stevens, Ryan Case, Joshua T. Pearson, Siyuan Liu, Patricia McElroy, Jude Canon, John R. Desjarlais, Angela Coxon, Mercedesz Balázs, Olivier Nolan-Stevaux	99
5	Dual Inhibition of Angiopoietin-TIE2 and MET Alters the Tumor Microenvironment and Prolongs Survival in a Metastatic Model of Renal Cell Carcinoma 2019 ·Molecular Cancer Therapeutics ·May Elbanna, Ashley Orillion, Nur P. Damayanti, Remi Adelaiye‐Ogala, Li Shen, Kiersten Marie Miles, Sreenivasulu Chintala, Eric Ciamporcero, Swathi Ramakrishnan, Sheng‐Yu Ku, Karen Rex, Sean Caenepeel, Angela Coxon, Роберто Пили	10
6	Dual Targeting of Aurora Kinases with AMG 900 Exhibits Potent Preclinical Activity Against Acute Myeloid Leukemia with Distinct Post-Mitotic Outcomes 2018 ·Molecular Cancer Therapeutics ·Marc Payton, (unknown), (unknown), Christian Marinaccio, (unknown), Kelly Hanestad, John D. Crispino, Gloria Juan, Angela Coxon	12
7	Preclinical Evaluation of AMG 337, a Highly Selective Small Molecule MET Inhibitor, in Hepatocellular Carcinoma 2016 ·Molecular Cancer Therapeutics ·Zhiqiang Du, Sean Caenepeel, Yuqing Shen, Karen Rex, Yanni Zhang, Ying He, En‐Tzu Tang, (unknown), Wenge Zhong, Hui Zhou, (unknown), Eric Huang, Liaoyuan A. Hu, Angela Coxon, (unknown)	18
8	In Vitro and In Vivo Activity of AMG 337, a Potent and Selective MET Kinase Inhibitor, in MET-Dependent Cancer Models 2016 ·Molecular Cancer Therapeutics ·Paul E. Hughes, Karen Rex, Sean Caenepeel, Yajing Yang, Yihong Zhang, Martin A. Broome, Hue T. Kha, Teresa L. Burgess, Benny Amore, Paula Kaplan‐Lefko, Jodi Moriguchi, Jonathan Werner, Michael A. Damore, D. N. Baker, Deborah M. Choquette, Jean-Christophe Harmange, Robert Radinsky, Richard Kendall, Isabelle Dussault, Angela Coxon	44
9	The MDM2 Inhibitor AMG 232 Demonstrates Robust Antitumor Efficacy and Potentiates the Activity of p53-Inducing Cytotoxic Agents 2015 ·Molecular Cancer Therapeutics ·Jude Canon, Tao Osgood, Steven H. Olson, Anne Y. Saiki, (unknown), Dongyin Yu, John Eksterowicz, Qiuping Ye, Lixia Jin, Ada Chen, Jing Zhou, David Cordover, Stephen A. Kaufman, Richard Kendall, Jonathan D. Oliner, Angela Coxon, Robert Radinsky	116
10	Identification of the Receptor Tyrosine Kinase c-Met and Its Ligand, Hepatocyte Growth Factor, as Therapeutic Targets in Clear Cell Sarcoma 2010 ·Cancer Research ·Ian J. Davis, Andrew W. McFadden, Yixiang Zhang, Angela Coxon, Teresa L. Burgess, Andrew J. Wagner, David E. Fisher	88
11	Safety, Pharmacokinetics, and Pharmacodynamics of AMG 102, a Fully Human Hepatocyte Growth Factor–Neutralizing Monoclonal Antibody, in a First-in-Human Study of Patients with Advanced Solid Tumors 2010 ·Clinical Cancer Research ·Michael S. Gordon, Christopher J. Sweeney, David S. Mendelson, S. Gail Eckhardt, Abraham Anderson, Darrin M. Beaupre, Daniel Branstetter, Teresa L. Burgess, Angela Coxon, Hongjie Deng, Paula Kaplan‐Lefko, Ian M. Leitch, Kelly S. Oliner, Lucy Yan, Min Zhu, Lia Gore	133
12	Complementary Actions of Inhibitors of Angiopoietin-2 and VEGF on Tumor Angiogenesis and Growth 2010 ·Cancer Research ·Hiroya Hashizume, Beverly L. Falcón, (unknown), Peter Bałuk, Angela Coxon, Dongyin Yu, James Bready, Jonathan D. Oliner, Donald M. McDonald	192
13	Augmentation of Radiation Response by Motesanib, a Multikinase Inhibitor that Targets Vascular Endothelial Growth Factor Receptors 2010 ·Clinical Cancer Research ·Tim J. Kruser, Deric L. Wheeler, Eric A. Armstrong, Mari Iida, Kevin R. Kozak, Albert J. van der Kogel, Johan Bussink, Angela Coxon, Anthony Polverino, Paul M. Harari	13
14	Biochemical Characterization of AMG 102: A Neutralizing, Fully Human Monoclonal Antibody to Human and Nonhuman Primate Hepatocyte Growth Factor 2010 ·Molecular Cancer Therapeutics ·Teresa L. Burgess, Jan Sun, Susanne Meyer, Trace S. Tsuruda, Jilin Sun, Gary Elliott, Qing Chen, Mitsuru Haniu, (unknown), Todd Juan, Ke Zhang, Angela Coxon, Richard Kendall	68
15	Contrasting Actions of Selective Inhibitors of Angiopoietin-1 and Angiopoietin-2 on the Normalization of Tumor Blood Vessels 2009 ·American Journal Of Pathology ·Beverly L. Falcón, Hiroya Hashizume, Petros Koumoutsakos, (unknown), James Bready, Angela Coxon, Jonathan D. Oliner, Donald M. McDonald	173
16	Identification of a Novel Recepteur d'Origine Nantais/c-Met Small-Molecule Kinase Inhibitor with Antitumor Activity In vivo 2008 ·Cancer Research ·Yihong Zhang, Paula Kaplan‐Lefko, Karen Rex, Yajing Yang, Jodi Moriguchi, Tao Osgood, (unknown), Angela Coxon, (unknown), Tae‐Seong Kim, Jasmine Lin, April Chen, Teresa L. Burgess, Isabelle Dussault	47
17	Exploratory biomarkers in the HGF/SF:c-Met axis: preclinical and clinical results 2008 ·Cancer Research ·Angela Coxon, Karen Rex, Jan Sun, Jodi Moriguchi, (unknown), Mark Ma, Abraham Anderson, Yun Lan, Michael A. Gordon, Lia Gore, Christopher Sweeney, Lucy Yan, Darrin M. Beaupre, Kelly S. Oliner, Teresa L. Burgess	2
18	AMG 655, a fully human agonistic antibody against TRAIL receptor-2, induces apoptosis via caspase activation in vitro and in vivo 2007 ·Cancer Research ·Paula Kaplan‐Lefko, (unknown), (unknown), (unknown), (unknown), Gloria Juan, (unknown), (unknown), Yang Pan, Steve Kaufman, Dan Branstetter, Angela Coxon, (unknown), Sharon Wong-Madden, Ian N. Foltz, Brian Gliniak	3
19	AMG 706 induces the rapid destruction of tumor microvessels in nude mice 2006 ·Cancer Research ·Stephen A. Kaufman, Charlie Starnes, Angela Coxon, Vinod F. Patel, Andrew S. Tasker, (unknown), Rick A. Kendall, Robert Radinsky, Russell C. Cattley	2
20	Polyneuritis associated with azathioprine sensitivity reaction. 1980 ·BMJ ·M J G Farthing, Angela Coxon, (unknown)	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact